$PRA

Lisenby Jeffrey Patton sold (to issuer) $2.5M of PRA

Lisenby Jeffrey Patton (Executive Vice-President) sold (to issuer) 98,066 shares of PROASSURANCE CORP (PRA) at $25.00 ($2.45M total) on 2026-06-26.

Original reporting
SEC EDGAR · Lisenby Jeffrey Patton
Published Jun 26, 2026, 4:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 4:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PRA
Neutral
medium confidence
Mentioned
$PRA
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PRANeutralLow
01

Why it matters

The newest disclosed fact is the size and price of the insider’s sale to the issuer, leaving holdings at 0 shares.

02

Market read

Traders may briefly reassess insider sentiment, but the event lacks fundamental catalysts and is typically low signal.

03

What to watch

No 10b5-1 plan is stated; however, absence of a plan in this snippet doesn’t prove opportunistic selling without additional context (e.g., prior filings, program details).

Relevance 6/10Novelty 3/10Timing: filed 2026-06-26 (after-hours/late session)

Background

The filing is an SEC Form 4 insider transaction for PROASSURANCE CORP (PRA) by an executive vice-president.

Company-level read

Ticker impact

$PRANeutralMedium confidence
Context

PROASSURANCE executive vice-president Lisenby Jeffrey Patton sold 98,066 shares to the issuer at $25.00/share on 2026-06-26.

Expected impact

Low near-term impact; any reaction is likely muted unless accompanied by unusual volume or follow-on disclosures.

Evidence & confidence

Form 4 provides a concrete transaction datapoint, but it is not an earnings/guidance/regulatory/operational catalyst and the filing does not indicate a change in company outlook.

Market effects

Minimal; this is company-specific insider transaction data with no sector-wide read-through.

None indicated.

None indicated.

Counterpoint

Because the sale is coded as “sale to issuer,” it may reflect scheduled buyback participation rather than bearish conviction.

Key entities

  • PROASSURANCE CORP

    Company whose insider transaction is disclosed on SEC Form 4.

  • Lisenby Jeffrey Patton

    Executive Vice-President who sold 98,066 shares to the issuer at $25.00/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATTOLowAI 8/10

GOLDMAN SACHS GROUP INC (WSLS OFFSHORE INVESTMENTS, SLP) purchased $10.3M of ATTO (indirect holdings)

GOLDMAN SACHS GROUP INC purchased 585,000 indirectly-held shares of Attovia Therapeutics, Inc. (ATTO) at an average of $17.58 ($17.00–$21.00, $10.28M total) across 2 trades over 2026-08-05 to 2026-08-06. Filed jointly with GOLDMAN SACHS & CO. LLC, GOLDMAN SACHS ASSET MANAGEMENT, L.P., Broad Street Principal Investments, L.L.C., WSLS OFFSHORE INVESTMENTS, SLP, West Street Life Sciences I, L.P., WSLS EMP OFFSHORE INVESTMENTS, L.P. and WSLS EMP ONSHORE INVESTMENTS, L.P..